x
0

AbbVie Inc (ABBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
65.840 +0.400    +0.61%
23/05 - Closed. Currency in USD ( Disclaimer )
After Hours
65.700
-0.140
-0.213%
23/05
Type: Equity
Market: United States
ISIN: US00287Y1091 
CUSIP: 00287Y109
  • Volume: 4,676,497
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 65.430 - 66.260
Start Trading
AbbVie 65.840 +0.400 +0.61%

ABBV Overview

 
Information about the AbbVie Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close65.44
Day's Range65.43 - 66.26
Revenue26.22B
Open65.44
52 wk Range55.062 - 68.124
EPS3.88
Volume4,676,497
Market Cap104.79B
Dividend (Yield)2.35 (3.89%)
Average Vol. (3m)5,905,130
P/E Ratio16.95
Beta1.54
1-Year Change11.03%
Shares Outstanding1,591,540,513
Next Earnings DateJul 27, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Buy Buy Buy Buy
Technical Indicators Strong Sell Neutral Strong Buy BUY Strong Buy
Summary Strong Sell Neutral Strong Buy Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish doji Star 15 Current
Abandoned Baby Bearish 30 Current
Completed Patterns
Deliberation Bearish 1D 5 May 16, 2017
Three Outside Up 1D 6 May 15, 2017
Three Black Crows 1M 7 Oct 16

AbbVie Inc News & Analysis

AbbVie Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 65.840 0.000 0.000 4,676,497 +0.61% USD 23/05  
  London 58.25 0.00 0.00 0 0% EUR 22/05  
  Mexico 1,225.40 0.00 0.00 0 0.00% MXN 19/05  
  Switzerland 65.250 0.000 0.000 0 0% CHF 08/03  
  Xetra 58.54 58.41 58.60 0 0.00% EUR 23/05  
  Frankfurt 58.69 58.77 59.05 0 -0.04% EUR 07:03:00  
  Stuttgart 59.060 58.810 59.060 16 +0.27% EUR 06:33:00  
  TradeGate 58.77 58.71 59.07 0 0.00% EUR 23/05  
  Munich 59.110 58.850 59.070 25 +2.07% EUR 06:07:00  
  Paris 59.490 0.000 0.000 0 0% EUR 18/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 153.80 154.90 153.31 -0.19 -0.12% 19.92M 23/05  
  Tata Motors 464.80 473.35 458.10 +14.30 +3.17% 19.51M 08:03:00  
  SBI 283.50 290.45 282.20 -5.35 -1.85% 10.80M 08:03:00  
  Daimler AG 66.440 66.670 66.220 -0.750 -1.12% 806.09K 08:07:06  
  DLF 189.45 199.35 186.60 -7.65 -3.88% 8.91M 08:03:00  
  OTP Bank 8,823.0 8,844.5 8,802.0 -37.0 -0.42% 78.54K 08:06:41  
  Tesla 303.86 310.73 303.48 -6.49 -2.09% 4.32M 23/05  
  ICICI Bank 306.80 309.65 305.25 +0.75 +0.25% 10.43M 08:03:00  
  AXIS Bank 497.00 505.00 495.00 -3.60 -0.72% 5.19M 08:03:00  
  Jindal Steel&Power 111.40 113.90 108.90 +3.25 +3.01% 14.60M 08:03:00  

AbbVie Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

30000

Equity Type

ORD

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading
No Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest ABBV Comments

Douglas Kaplan
Douglas Kaplan Feb 09, 2017 7:31PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I thought this stock had a very good future, I am doubting myself now? It was on track to be close to $100.00 in 2017.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.